Carole Bourquin

University of Bern — Switzerland

Immunology and Microbiology · Life Sciences

37h-index6.6kcitations138works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(44), Immune Response and Inflammation(41), Immune Cell Function and Interaction(35), Chemokine receptors and signaling(21), T-cell and B-cell Immunology(18)

Publications138 total

Unraveling the role of 3-mercaptopyruvate sulfurtransferase-derived hydrogen sulfide in triple-negative breast cancer chemoresistance
Frontiers in Pharmacology·2026Open Access
Mitochondrial Dysfunction Rewires Macrophage Metabolism, Driving Pro-inflammatory Priming and Immune System Remodeling
2025Open Access
Inhibition of 3-mercaptopyruvate sulfurtransferase enhances CD8⁺ T-cell antitumor immunity
2025Open Access
WITHDRAWN: 474P Disrupting mitochondrial biogenesis in triple-negative breast cancer via 3-MST inhibition
Annals of Oncology·2025
Estrogens determine the efficacy of cancer immunotherapy in obese males with melanoma
JCI Insight·2025· 1 citedOpen Access
Selective molecular inhibition of the HDAC6 ZnF-UBP binding domain impairs multiple myeloma cell function
Cell Death Discovery·2025· 3 citedOpen Access
Innate Immune Activation Is a Strong Suppressor of <scp>CCL22</scp> and Impedes Regulatory T Cell–Dendritic Cell Interaction
Immunology·2025· 1 citedOpen Access
Tissular glucocorticoid reactivating enzyme 11β-HSD1 drives pathogenic myofibroblast differentiation in chronic kidney disease
2025
Emerging roles of hydrogen sulfide-metabolizing enzymes in cancer
UNC Libraries·2024Open Access
Emerging roles of hydrogen sulfide-metabolizing enzymes in cancer
Redox Report·2024· 12 citedOpen Access
GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer model
Frontiers in Immunology·2024· 1 citedOpen Access
Selective molecular inhibition of the HDAC6 ZnF-UBP binding domain impairs multiple myeloma cell proliferation
2024· 1 citedOpen Access
Pan-inhibition of the three H2S synthesizing enzymes restrains tumor progression and immunosuppression in breast cancer
Cancer Cell International·2024· 21 citedOpen Access
107P Inhibition of hydrogen sulfide biosynthesis influences mitochondrial biogenesis in breast cancer
ESMO Open·2024Open Access
Role of Hydrogen Sulfide in Oncological and Non-Oncological Disorders and Its Regulation by Non-Coding RNAs: A Comprehensive Review
Non-Coding RNA·2024· 17 citedOpen Access
175P MicroRNA-548c: An immune-activator microRNA at the tumor microenvironment and immune milieu of breast cancer
Immuno-Oncology Technology·2023Open Access
Activation of endogenous glucocorticoids by HSD11B1 inhibits the antitumor immune response in renal cancer
OncoImmunology·2023· 15 citedOpen Access
Dual targeting of H2S synthesizing enzymes; cystathionine β-synthase and cystathionine γ-lyase by miR-939-5p effectively curbs triple negative breast cancer
Heliyon·2023· 19 citedOpen Access
2280P MiR-193a-3p: A pan-repressor of H2S synthesizing enzymes regulates tumorigenesis and immunosurveillance in breast cancer
Annals of Oncology·2023· 3 citedOpen Access
Related CCR Translation from CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Stefan Endres(24), David Anz(18), Gunther Hartmann(8), Inès Mottas(8), Veit Hornung(7), Nadja Sandholzer(7), C. Hotz(7), Cornelia Wurzenberger(6), Thibaud Spinetti(5), Simon Heidegger(5), Simon Rothenfußer(5), Moritz Rapp(5), Christopher Linington(5), Hendrik Poeck(4), Raffael Thaler(4), Gerhard Winter(4), Lorenzo Spagnuolo(4), Jérôme Widmer(4), Sascha Haubner(3), Stefan Moder(3)